NQWM
PFE icon

Northwest Quadrant Wealth Management’s Pfizer PFE Stock Holding History

Northwest Quadrant Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,353
Closed -$223K – 58
2022
Q4 		$223K Buy
+4,353
New +$209K 0.07% 54
2022
Q3 		– Sell
-5,271
Closed -$272K – 57
2022
Q2 		$272K Buy
5,271
+317
+6% +$16.2K 0.08% 47
2022
Q1 		$252K Sell
4,954
-75
-1% -$3.89K 0.07% 58
2021
Q4 		$297K Buy
5,029
+121
+2% +$6K 0.08% 48
2021
Q3 		$214K Sell
4,908
-391
-7% -$17.3K 0.06% 64
2021
Q2 		$207K Buy
+5,299
New +$206K 0.06% 65
2021
Q1 		– Sell
-5,905
Closed -$217K – 65
2020
Q4 		$217K Sell
5,905
-449
-7% -$16.5K 0.07% 55
2020
Q3 		$218K Buy
+6,354
New +$223K 0.09% 53
2020
Q2 		– Sell
-6,391
Closed -$224K – 58
2020
Q1 		$224K Sell
6,391
-706
-10% -$24.1K 0.1% 49
2019
Q4 		$262K Sell
7,097
-936
-12% -$33.3K 0.11% 53
2019
Q3 		$278K Buy
8,033
+1,335
+20% +$48.5K 0.12% 51
2019
Q2 		$276K Sell
6,698
-162
-2% -$6.43K 0.13% 49
2019
Q1 		$279K Buy
6,860
+33
+0.5% +$1.32K 0.13% 48
2018
Q4 		$256K Buy
6,827
+31
+0.5% +$1.29K 0.13% 50
2018
Q3 		$283K Buy
6,796
+34
+0.5% +$1.31K 0.17% 41
2018
Q2 		$233K Buy
6,762
+41
+0.6% +$1.4K 0.16% 48
2018
Q1 		$226K Buy
6,721
+42
+0.6% +$1.44K 0.15% 55
2017
Q4 		$220K Sell
6,679
-43
-0.6% -$1.47K 0.15% 57
2017
Q3 		$225K Buy
6,722
+51
+0.8% +$1.64K 0.17% 56
2017
Q2 		$211K Buy
6,671
+53
+0.8% +$1.67K 0.18% 56
2017
Q1 		$210K Sell
6,618
-89
-1% -$2.81K 0.2% 58
2016
Q4 		$205K Buy
+6,707
New +$205K 0.22% 57

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northwest Quadrant Wealth Management's PFE Position: Q1 2023 in Review

Northwest Quadrant Wealth Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,353 shares — an estimated $223K sold.

Northwest Quadrant Wealth Management first reported a position in PFE in Q4 2016 and held it in 22 quarters. The position peaked at $297K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Northwest Quadrant Wealth Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Northwest Quadrant Wealth Management sold 4,353 Pfizer shares in Q1 2023, an estimated $223K.
  • Northwest Quadrant Wealth Management first reported a position in Pfizer in Q4 2016 and held it in 22 quarters.
  • Northwest Quadrant Wealth Management's Pfizer position peaked at $297K in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Northwest Quadrant Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.